We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$264B
AUM Growth
+$16.6B
(+6.7%)
Cap. Flow
-$3.28B
Cap. Flow
% of AUM
-1.24%
Top 10 Holdings %
Top 10 Hldgs %
18.75%
Holding
3,331
New
118
Increased
1,090
Reduced
1,840
Closed
95
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.03B |
| 2 |
Bristol-Myers Squibb
BMY
|
+$649M |
| 3 |
NVIDIA
NVDA
|
+$329M |
| 4 |
AT&T
T
|
+$316M |
| 5 |
Tesla
TSLA
|
+$313M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$474M |
| 2 |
CELG
Celgene Corp
CELG
|
+$421M |
| 3 |
Broadcom
AVGO
|
+$411M |
| 4 |
Netflix
NFLX
|
+$387M |
| 5 |
Apple
AAPL
|
+$372M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.51% |
| 2 | Financials | 14.64% |
| 3 | Healthcare | 13.3% |
| 4 | Consumer Discretionary | 10.29% |
| 5 | Communication Services | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
BancFirst
BANF
$3.8B
| $7.27M | ﹤0.01% |
116,462
+14,251
| +14% | +$839K |
|
1777
Enanta Pharmaceuticals
ENTA
$400M
| $7.27M | ﹤0.01% |
117,651
-92,118
| -44% | -$5.71M |
|
1778
Westamerica Bancorp
WABC
$1.37B
| $7.26M | ﹤0.01% |
107,202
-2,190
| -2% | -$143K |
|
1779
Antero Midstream
AM
$10.1B
| $7.25M | ﹤0.01% |
954,997
+106,624
| +13% | +$674K |
|
1780
Carriage Services
CSV
$569M
| $7.25M | ﹤0.01% |
283,135
+16,410
| +6% | +$398K |
|
1781
Ducommun
DCO
$2.98B
| $7.25M | ﹤0.01% |
143,411
+7,097
| +5% | +$327K |
|
|
INVX
1782
Innovex International
INVX
$1.97B
| $7.24M | ﹤0.01% |
154,432
-1,887
| -1% | -$86.4K |
|
|
PDCO
1783
DELISTED
Patterson Companies, Inc.
PDCO
| $7.23M | ﹤0.01% |
352,909
-657
| -0.2% | -$12.4K |
|
|
IRBT
1784
DELISTED
iRobot
IRBT
| $7.21M | ﹤0.01% |
142,483
+1,991
| +1% | +$100K |
|
1785
Assembly Biosciences
ASMB
$529M
| $7.21M | ﹤0.01% |
29,360
+11,305
| +63% | +$2.08M |
|
1786
Interparfums
IPAR
$3.94B
| $7.17M | ﹤0.01% |
98,598
-12,961
| -12% | -$943K |
|
1787
Bloomin' Brands
BLMN
$938M
| $7.16M | ﹤0.01% |
324,405
-6,466
| -2% | -$137K |
|
1788
Group 1 Automotive
GPI
$3.18B
| $7.15M | ﹤0.01% |
71,521
+5,390
| +8% | +$532K |
|
|
PTLA
1789
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $7.15M | ﹤0.01% |
299,391
-3,110
| -1% | -$85.8K |
|
1790
Avis
CAR
$5.02B
| $7.15M | ﹤0.01% |
221,692
-30,798
| -12% | -$924K |
|
|
DMC
1791
Del Monte Corp
DMC
$1.45B
| $7.14M | ﹤0.01% |
204,114
-1,070
| -0.5% | -$34.2K |
|
1792
Northwest Bancshares
NWBI
$2.28B
| $7.14M | ﹤0.01% |
429,099
+35,814
| +9% | +$599K |
|
1793
Supernus Pharmaceuticals
SUPN
$2.77B
| $7.1M | ﹤0.01% |
299,423
-335,068
| -53% | -$8.14M |
|
1794
TFS Financial
TFSL
$4.93B
| $7.1M | ﹤0.01% |
360,878
-14,238
| -4% | -$275K |
|
1795
8x8 Inc
EGHT
$332M
| $7.1M | ﹤0.01% |
387,764
-3,038
| -0.8% | -$58.6K |
|
|
INST
1796
DELISTED
Instructure, Inc.
INST
| $7.1M | ﹤0.01% |
147,189
+9,094
| +7% | +$427K |
|
1797
Caleres
CAL
$487M
| $7.08M | ﹤0.01% |
298,083
-162,582
| -35% | -$3.67M |
|
|
X
1798
DELISTED
US Steel
X
| $7.08M | ﹤0.01% |
620,303
-39,563
| -6% | -$491K |
|
1799
Granite Construction
GVA
$5.62B
| $7.06M | ﹤0.01% |
255,033
+58,138
| +30% | +$1.65M |
|
1800
Peoples Bancorp
PEBO
$1.47B
| $7.05M | ﹤0.01% |
203,472
+1,444
| +0.7% | +$47.2K |
|
Similar funds
VFT
Nuveen's Q4 2019 Portfolio in Review
As of Q4 2019, Nuveen held 3,331 positions worth $264B, up 6.7% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen's Q4 2019 filing shows 118 new, 1,090 increased, 1,840 reduced and 95 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B. The largest sale was Cisco, an estimated $474M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Nuveen's largest Q4 2019 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B.
- Nuveen added most to Bristol-Myers Squibb in Q4 2019, an estimated $649M increase.
- Nuveen's biggest Q4 2019 reduction was Cisco, cutting an estimated $474M.
- Nuveen fully exited Celgene Corp in Q4 2019, selling an estimated $421M.
- Nuveen's ten largest holdings make up 19% of its $264B portfolio in Q4 2019.
- Nuveen opened 118 new positions and closed 95 in Q4 2019.
- Nuveen's portfolio value rose 6.7% quarter-over-quarter to $264B.
Based on Nuveen's 13F filing for Q4 2019, filed 14 Feb 2020.